APAC CIOOutlook

Advertise

with us

  • Technologies
      • Artificial Intelligence
      • Big Data
      • Blockchain
      • Cloud
      • Digital Transformation
      • Internet of Things
      • Low Code No Code
      • MarTech
      • Mobile Application
      • Security
      • Software Testing
      • Wireless
  • Industries
      • E-Commerce
      • Education
      • Logistics
      • Retail
      • Supply Chain
      • Travel and Hospitality
  • Platforms
      • Microsoft
      • Salesforce
      • SAP
  • Solutions
      • Business Intelligence
      • Cognitive
      • Contact Center
      • CRM
      • Cyber Security
      • Data Center
      • Gamification
      • Procurement
      • Smart City
      • Workflow
  • Home
  • CXO Insights
  • CIO Views
  • Vendors
  • News
  • Conferences
  • Whitepapers
  • Newsletter
  • Awards
Apac
  • Artificial Intelligence

    Big Data

    Blockchain

    Cloud

    Digital Transformation

    Internet of Things

    Low Code No Code

    MarTech

    Mobile Application

    Security

    Software Testing

    Wireless

  • E-Commerce

    Education

    Logistics

    Retail

    Supply Chain

    Travel and Hospitality

  • Microsoft

    Salesforce

    SAP

  • Business Intelligence

    Cognitive

    Contact Center

    CRM

    Cyber Security

    Data Center

    Gamification

    Procurement

    Smart City

    Workflow

Menu
    • AI
    • Cyber Security
    • Hotel Management
    • Workflow
    • E-Commerce
    • Business Intelligence
    • MORE
    #

    Apac CIOOutlook Weekly Brief

    ×

    Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Apac CIOOutlook

    Subscribe

    loading

    THANK YOU FOR SUBSCRIBING

    • Home
    • Artificial Intelligence
    Editor's Pick (1 - 4 of 8)
    left
    The Right Technology And Reliable Partners; The Business Next Frontier

    Luke O'Brien, CIO, ISS Facility Services Australia & New Zealand

    Conquering Technological Transformation

    David Kennedy, Group CIO, Transaction Services Group

    How to Get to AI-first

    Ani Paul, CIO, ING Australia

    Legal Knowledge Management and the Rise of Artificial Intelligence

    Christopher Zegers, CIO, Lowenstein Sandler LLP

    Building an AI-Based Machine Learning for Global Economics

    Alexander Fleiss, CIO & CEO, Rebellion Research Partners LP

    Harnessing AI to Optimize Manufacturing and Logistics

    Anton Setiawan, General Manager, Information Technology, PT Panca Budi Idaman TBK (IDX:PBID)

    Building Agile, Secure and Human-Centered IT at Globe

    Raul Macatangay, Chief Information Officer, Globe Telecom

    AI Adoption in Hospitality: Striking the Balance Between Innovation, Excellence and Trust

    Phiphat Khanonwet, Head of IT, Onyx Hospitality Group

    right

    Insilico Forms Research Collaboration with Taisho

    Tweet

    Insilico Medicine and Taisho Pharmaceutical have entered into a research collaboration to find novel therapeutics against aging.

    Fremont, CA: Insilico Medicine and Taisho Pharmaceutical have entered into a research collaboration to find novel therapeutics against aging. Insilico will utilize both the target discovery and generative chemistry parts of its Pharma.AI platform in this collaboration. The firm will also use its proprietary Pandomics Discovery Platform to identify novel targets for senolytic drugs and Chemistry42 platform for a molecular generation. This new collaboration brings together Insilico's state-of-art artificial intelligence (AI) technologies in drug discovery with Taisho's expertise in drug development, mainly focused on extending human healthspan.

    "We're delighted to collaborate with Taisho pharmaceutical, a well-recognized leader in the pharmaceutical industry and healthcare sector. It is believed that aging is a universal phenomenon that we cannot stop. However, emerging scientific evidence has shown that one may be able to reverse some of the age-associated processes. Through this collaboration, we will adopt our AI-powered drug discovery suites together with Taisho's validation platform to explore the new space of anti-aging solutions," said Jimmy Yen-Chu Lin, Ph.D., CEO of Insilico Medicine Taiwan, a fully-owned subsidiary of Insilico Medicine

    Under the terms of the collaboration agreement, Insilico will receive an upfront payment and milestone payments upon achieving specified goals. The firm will be responsible for the early research phase target identification and molecular generation. Taisho will work collaboratively with Insilico in validating the results in various in vitro and in vivo assays. Taisho has the exclusive option to acquire Insilico's co-ownership of the successfully developed programs under the agreed payment.

    "It is our great honor to be collaborating with the scientists of Taisho Pharmaceutical, one of the top 100 pharmaceutical companies in the world operating since 1912. The high level of the scientists we are interfacing, and our previous successes in the application of the Pharma.AI platform for discovery of novel targets and molecules in fibrosis, and previous experience in senolytic drug discovery give us confidence that this collaboration will be successful," said Alex Zhavoronkov, Ph.D., founder and CEO of Insilico Medicine.

    tag

    Pharmaceutical

    Weekly Brief

    loading
    Top 20 Prominent Artificial Intelligence Solutions Providers in APAC - 2024
    ON THE DECK

    I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

    Read Also

    Loading...
    Copyright © 2025 APAC CIOOutlook. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Use and Privacy and Anti Spam Policy 

    Home |  CXO Insights |   Whitepapers |   Subscribe |   Conferences |   Sitemaps |   About us |   Advertise with us |   Editorial Policy |   Feedback Policy |  

    follow on linkedinfollow on twitter follow on rss
    This content is copyright protected

    However, if you would like to share the information in this article, you may use the link below:

    https://artificial-intelligence.apacciooutlook.com/press-release/insilico-forms-research-collaboration-with-taisho-nwid-7797.html